Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review

Vivian Y. Shi; Winston Chamberlain; Elaine Siegfried; Cheryl Kraff-Cooper; Kenneth Beckman; Peter Lio; Amy S. Paller; Eric Simpson

doi:10.1016/j.jaad.2023.01.043

Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review

Vivian Y. Shi
, Winston Chamberlain
, Elaine Siegfried
, Cheryl Kraff-Cooper
, Kenneth Beckman
, Peter Lio
, Amy S. Paller
, Eric Simpson

Research output: Contribution to journal › Review article › peer-review

16 Scopus citations

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin disease that can significantly decrease quality of life. AD is commonly associated with comorbidities including ocular surface disease (OSD). Conjunctivitis is the most common OSD associated with AD and can increase in incidence with use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The objective of this review is to raise awareness of comorbid OSD in AD patients that dermatologists may encounter, with a focus on conjunctivitis, and equip dermatologists to address mild ocular concerns. We provide background on the subtypes and pathogenesis of comorbid OSD in AD patients and describe OSD associated with type 2 inflammation-inhibiting AD biologics. We also discuss screening and diagnosis, recommended treatment options for dermatologists, and when to refer to an eye care specialist. This multispecialty approach aims to support the overall health of AD patients and provide optimal patient care.

Original language	English (US)
Pages (from-to)	309-315
Number of pages	7
Journal	Journal of the American Academy of Dermatology
Volume	89
Issue number	2
DOIs	https://doi.org/10.1016/j.jaad.2023.01.043
State	Published - Aug 1 2023

Funding

Funding sources: Medical writing support was funded by LEO Pharma A/S, according to Good Publication Practice guidelines (https://www.ismpp.org/gpp3). The authors received no honoraria related to the development of this publication.Medical writing support, including assisting authors with the development of the manuscript drafts and incorporation of comments, was provided by Meredith Whitaker, PhD, and Krista Mills of Alphabet Health (New York, NY), supported by LEO Pharma A/S, according to Good Publication Practice guidelines (https://www.ismpp.org/gpp3).

Funders
Meredith Whitaker

Keywords

atopic dermatitis
biologics
conjunctivitis
eczema
multispecialty care
ocular surface disease

ASJC Scopus subject areas

Dermatology

Access to Document

10.1016/j.jaad.2023.01.043

Cite this

@article{dbe1efabda3142b7bb8c73bbabcbaa56,

title = "Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review",

abstract = "Atopic dermatitis (AD) is a chronic inflammatory skin disease that can significantly decrease quality of life. AD is commonly associated with comorbidities including ocular surface disease (OSD). Conjunctivitis is the most common OSD associated with AD and can increase in incidence with use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The objective of this review is to raise awareness of comorbid OSD in AD patients that dermatologists may encounter, with a focus on conjunctivitis, and equip dermatologists to address mild ocular concerns. We provide background on the subtypes and pathogenesis of comorbid OSD in AD patients and describe OSD associated with type 2 inflammation-inhibiting AD biologics. We also discuss screening and diagnosis, recommended treatment options for dermatologists, and when to refer to an eye care specialist. This multispecialty approach aims to support the overall health of AD patients and provide optimal patient care.",

keywords = "atopic dermatitis, biologics, conjunctivitis, eczema, multispecialty care, ocular surface disease",

author = "Shi, \{Vivian Y.\} and Winston Chamberlain and Elaine Siegfried and Cheryl Kraff-Cooper and Kenneth Beckman and Peter Lio and Paller, \{Amy S.\} and Eric Simpson",

note = "Publisher Copyright: {\textcopyright} 2023 American Academy of Dermatology, Inc.",

year = "2023",

month = aug,

day = "1",

doi = "10.1016/j.jaad.2023.01.043",

language = "English (US)",

volume = "89",

pages = "309--315",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis

T2 - A review

AU - Shi, Vivian Y.

AU - Chamberlain, Winston

AU - Siegfried, Elaine

AU - Kraff-Cooper, Cheryl

AU - Beckman, Kenneth

AU - Lio, Peter

AU - Paller, Amy S.

AU - Simpson, Eric

PY - 2023/8/1

Y1 - 2023/8/1

N2 - Atopic dermatitis (AD) is a chronic inflammatory skin disease that can significantly decrease quality of life. AD is commonly associated with comorbidities including ocular surface disease (OSD). Conjunctivitis is the most common OSD associated with AD and can increase in incidence with use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The objective of this review is to raise awareness of comorbid OSD in AD patients that dermatologists may encounter, with a focus on conjunctivitis, and equip dermatologists to address mild ocular concerns. We provide background on the subtypes and pathogenesis of comorbid OSD in AD patients and describe OSD associated with type 2 inflammation-inhibiting AD biologics. We also discuss screening and diagnosis, recommended treatment options for dermatologists, and when to refer to an eye care specialist. This multispecialty approach aims to support the overall health of AD patients and provide optimal patient care.

AB - Atopic dermatitis (AD) is a chronic inflammatory skin disease that can significantly decrease quality of life. AD is commonly associated with comorbidities including ocular surface disease (OSD). Conjunctivitis is the most common OSD associated with AD and can increase in incidence with use of monoclonal antibody biologics that target the type 2 inflammatory pathway. The objective of this review is to raise awareness of comorbid OSD in AD patients that dermatologists may encounter, with a focus on conjunctivitis, and equip dermatologists to address mild ocular concerns. We provide background on the subtypes and pathogenesis of comorbid OSD in AD patients and describe OSD associated with type 2 inflammation-inhibiting AD biologics. We also discuss screening and diagnosis, recommended treatment options for dermatologists, and when to refer to an eye care specialist. This multispecialty approach aims to support the overall health of AD patients and provide optimal patient care.

KW - atopic dermatitis

KW - biologics

KW - conjunctivitis

KW - eczema

KW - multispecialty care

KW - ocular surface disease

UR - https://www.scopus.com/pages/publications/85151893453

UR - https://www.scopus.com/pages/publications/85151893453#tab=citedBy

U2 - 10.1016/j.jaad.2023.01.043

DO - 10.1016/j.jaad.2023.01.043

M3 - Review article

C2 - 36806642

AN - SCOPUS:85151893453

SN - 0190-9622

VL - 89

SP - 309

EP - 315

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2

ER -

Practical management of ocular surface disease in patients with atopic dermatitis, with a focus on conjunctivitis: A review

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this